Header Logo

Connection

Lee Fairlie to Child

Back to Details
This is a "connection" page, showing publications Lee Fairlie has written about Child.
Lee Fairlie
Connection Strength
1,538
Child
  1. HIV treatment success in children and adolescents with HIV. Lancet HIV. 2022 08; 9(8):e526-e527.
    View in: PubMed
    Score: 0,129
  2. Lamivudine monotherapy in children and adolescents: The devil is in the detail. S Afr Med J. 2017 Nov 27; 107(12):1055-1057.
    View in: PubMed
    Score: 0,094
  3. CD4+ and viral load outcomes of antiretroviral therapy switch strategies after virologic failure of combination antiretroviral therapy in perinatally HIV-infected youth in the United States. AIDS. 2015 Oct 23; 29(16):2109-19.
    View in: PubMed
    Score: 0,081
  4. Outcomes in treatment with darunavir/ritonavir in ART-experienced paediatric patients. S Afr Med J. 2015 Apr 08; 105(5):330-1.
    View in: PubMed
    Score: 0,078
  5. Providing comprehensive health services for young key populations: needs, barriers and gaps. J Int AIDS Soc. 2015; 18(2 Suppl 1):19833.
    View in: PubMed
    Score: 0,077
  6. Microbiological investigation for tuberculosis among HIV-infected children in Soweto, South Africa. Int J Tuberc Lung Dis. 2014 Jun; 18(6):676-81.
    View in: PubMed
    Score: 0,073
  7. High prevalence of childhood multi-drug resistant tuberculosis in Johannesburg, South Africa: a cross sectional study. BMC Infect Dis. 2011 Jan 26; 11:28.
    View in: PubMed
    Score: 0,058
  8. Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis. Lancet Child Adolesc Health. 2025 Feb; 9(2):100-111.
    View in: PubMed
    Score: 0,038
  9. Safety and immunogenicity of Ad26.COV2.S in adolescents: Phase 2 randomized clinical trial. Hum Vaccin Immunother. 2025 Dec; 21(1):2450120.
    View in: PubMed
    Score: 0,038
  10. Levofloxacin Preventive Treatment in Children Exposed to MDR Tuberculosis. N Engl J Med. 2024 Dec 19; 391(24):2315-2326.
    View in: PubMed
    Score: 0,038
  11. A Meta-Analysis of Levofloxacin for Contacts of Multidrug-Resistant Tuberculosis. NEJM Evid. 2025 Jan; 4(1):EVIDoa2400190.
    View in: PubMed
    Score: 0,038
  12. Burden of Lassa fever disease in pregnant women and children and options for prevention. Vaccine. 2025 Jan 01; 43(Pt 1):126479.
    View in: PubMed
    Score: 0,038
  13. South African Parents' and Grandparents' Perspectives on the Acceptability of Implant Delivery of Treatment to Young Children with HIV. AIDS Behav. 2025 Jan; 29(1):13-21.
    View in: PubMed
    Score: 0,038
  14. Translating the consent form is the tip of the iceberg: using cognitive interviews to assess the barriers to informed consent in South African health facilities. Sex Reprod Health Matters. 2023 Dec; 31(4):2302553.
    View in: PubMed
    Score: 0,036
  15. Population Pharmacokinetic Modeling of Dolutegravir to Optimize Pediatric Dosing in HIV-1-Infected Infants, Children, and Adolescents. Clin Pharmacokinet. 2023 10; 62(10):1445-1459.
    View in: PubMed
    Score: 0,035
  16. Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet HIV. 2023 06; 10(6):e363-e374.
    View in: PubMed
    Score: 0,034
  17. Acceptability of Implants for HIV Treatment in Young Children: Perspectives of Health Care Providers in Johannesburg, South Africa. AIDS Patient Care STDS. 2022 10; 36(10):389-395.
    View in: PubMed
    Score: 0,033
  18. Approaches to accelerating the study of new antiretrovirals in pregnancy. J Int AIDS Soc. 2022 07; 25 Suppl 2:e25916.
    View in: PubMed
    Score: 0,032
  19. Pharmacokinetics and safety of high-dose rifampicin in children with TB: the Opti-Rif trial. J Antimicrob Chemother. 2021 11 12; 76(12):3237-3246.
    View in: PubMed
    Score: 0,031
  20. Challenges in recruiting children to a multidrug-resistant TB prevention trial. Int J Tuberc Lung Dis. 2021 10 01; 25(10):814-822.
    View in: PubMed
    Score: 0,031
  21. Ethically designing research to inform multidimensional, rapidly evolving policy decisions: Lessons learned from the PROMISE HIV Perinatal Prevention Trial. Clin Trials. 2021 12; 18(6):681-689.
    View in: PubMed
    Score: 0,030
  22. Etravirine in treatment-experienced HIV-1-infected children 1 year to less than 6 years of age. AIDS. 2021 07 15; 35(9):1413-1421.
    View in: PubMed
    Score: 0,030
  23. Assessing pregnancy and neonatal outcomes in Malawi, South Africa, Uganda, and Zimbabwe: Results from a systematic chart review. PLoS One. 2021; 16(3):e0248423.
    View in: PubMed
    Score: 0,029
  24. Pharmacokinetics and Safety of a Raltegravir-Containing Regimen in Children Aged 4 Weeks to 2 Years Living With Human Immunodeficiency Virus and Receiving Rifampin for Tuberculosis. J Pediatric Infect Dis Soc. 2021 Mar 26; 10(2):201-204.
    View in: PubMed
    Score: 0,029
  25. African Multi-Site 2-Year Neuropsychological Study of School-Age Children Perinatally Infected, Exposed, and Unexposed to Human Immunodeficiency Virus. Clin Infect Dis. 2020 10 23; 71(7):e105-e114.
    View in: PubMed
    Score: 0,029
  26. Virologic response to efavirenz-based first-line antiretroviral therapy in children with previous exposure to antiretrovirals to prevent mother-to-child transmission. PLoS One. 2020; 15(5):e0233693.
    View in: PubMed
    Score: 0,028
  27. Abacavir Exposure in Children Cotreated for Tuberculosis with Rifampin and Superboosted Lopinavir-Ritonavir. Antimicrob Agents Chemother. 2020 04 21; 64(5).
    View in: PubMed
    Score: 0,028
  28. Association between caregiver depression symptoms and child executive functioning. Results from an observational study carried out in four sub-Saharan countries. AIDS Care. 2020 04; 32(4):486-494.
    View in: PubMed
    Score: 0,026
  29. What Should We Do When HIV-positive Children Fail First-line Combination Antiretroviral Therapy? A Comparison of 4 ART Management Strategies. Pediatr Infect Dis J. 2019 04; 38(4):400-405.
    View in: PubMed
    Score: 0,026
  30. Mortality and losses to follow-up among adolescents living with HIV in the IeDEA global cohort collaboration. J Int AIDS Soc. 2018 12; 21(12):e25215.
    View in: PubMed
    Score: 0,025
  31. Lamivudine monotherapy as a holding regimen for HIV-positive children. PLoS One. 2018; 13(10):e0205455.
    View in: PubMed
    Score: 0,025
  32. Building capacity in neurodevelopment assessment of children in sub-Saharan Africa: A quality assurance model to implement standardized neurodevelopment testing. Child Neuropsychol. 2019 05; 25(4):466-481.
    View in: PubMed
    Score: 0,025
  33. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis. PLoS Med. 2018 07; 15(7):e1002591.
    View in: PubMed
    Score: 0,024
  34. Neuropsychological performance in African children with HIV enrolled in a multisite antiretroviral clinical trial. AIDS. 2018 01 14; 32(2):189-204.
    View in: PubMed
    Score: 0,024
  35. Decline in CD4 T lymphocytes with monotherapy bridging strategy for non-adherent adolescents living with HIV infection: Results of the IMPAACT P1094 randomized trial. PLoS One. 2017; 12(6):e0178075.
    View in: PubMed
    Score: 0,023
  36. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome in children. Pediatr Pulmonol. 2016 Feb; 51(2):157-64.
    View in: PubMed
    Score: 0,020
  37. Evaluation of parent-child pairs on antiretroviral therapy in separate adult and pediatric clinics. J Int Assoc Provid AIDS Care. 2014 Nov-Dec; 13(6):555-9.
    View in: PubMed
    Score: 0,018
  38. Frequency of stavudine substitution due to toxicity in children receiving antiretroviral treatment in sub-Saharan Africa. AIDS. 2013 Mar 13; 27(5):781-5.
    View in: PubMed
    Score: 0,017
  39. Predictors of loss to follow-up among children in the first and second years of antiretroviral treatment in Johannesburg, South Africa. Glob Health Action. 2013 Jan 24; 6:19248.
    View in: PubMed
    Score: 0,017
  40. Cost and outcomes of paediatric antiretroviral treatment in South Africa. AIDS. 2013 Jan 14; 27(2):243-50.
    View in: PubMed
    Score: 0,017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.